Versant Capital Management’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
Other funds holding AVBP
TE
MAP
EA
YIH
PR
GI
TM
MPWT
Versant Capital Management's AVBP Position: Q2 2026 in Review
Versant Capital Management held its ArriVent BioPharma (AVBP) position steady in Q2 2026 at 423 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2083.
Versant Capital Management first reported a position in AVBP in Q2 2025 and has held it in 5 quarters since. 9 funds tracked by Wall St. Rank hold AVBP as of Q2 2026.
- Versant Capital Management held 423 shares of ArriVent BioPharma worth $14.7K as of Q2 2026.
- Versant Capital Management left its ArriVent BioPharma share count unchanged in Q2 2026.
- ArriVent BioPharma made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2083 holding.
- Versant Capital Management first reported a position in ArriVent BioPharma in Q2 2025 and has held it in 5 quarters since.
- 9 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.